Pharmaceutical companies are undergoing a profound transformation. No longer confined to merely developing treatments, companies are assuming a partnership role to collaborate with healthcare ...
Patients aren’t the only healthcare participants who believe self-care is necessary since the COVID-19 pandemic – 86.6% of healthcare professionals now believe so, too. However, connecting patients ...
Behavioral and engagement insights are helping biopharma companies design more personalized patient support programs that improve persistence and long-term outcomes. Standardized patient support ...
About 1 in 10 prescription drugs - mainly brand-name and expensive drugs and those for rare diseases - has a manufacturer-sponsored patient support program, which usually includes financial, nursing ...
About one in 10 prescription drugs—mainly brand-name and expensive drugs and those for rare diseases—has a manufacturer-sponsored patient support program, which usually includes financial, nursing and ...
Greater transparency and independent evaluation are needed to understand the impact of the patient support programs that pharmaceutical companies offer for many expensive drugs, according to ...
Is the accelerator working? An updated empirical analysis of FDA accelerated approvals. This is an ASCO Meeting Abstract from the 2026 ASCO Annual Meeting I. This abstract does not include a full text ...
While much attention has been given to the novel science behind cell and gene therapies (CGTs), the success of every precision medicine starts and ends with the patient. The novel science behind CGTs ...
Traditional interventions are largely offline, lack continuous support, and primarily focus on improving knowledge. This study aimed to explore the feasibility, acceptability, and preliminary effects ...
As specialty medicines play a growing role in healthcare, the patient journey that follows is equally critical.
With chronic disease rates rising across the U.S., healthcare systems face ongoing challenges in reducing hospital stays and readmissions. Nearly 1 in 4 heart failure patients is readmitted to the ...
About 1 in 10 prescription drugs — mainly brand-name and expensive drugs and those for rare diseases — has a manufacturer-sponsored patient support program, which usually includes financial, nursing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results